ERC Advanced grant awarded to Thomas Helleday

18Feb11

The European Research Council (ERC) has awarded Thomas Helleday 2.5 million euros over 5 years for the project “Genetic Networks as a tool for anti-Cancer Drug-Development”. The ERC supports high-risk high-gain projects and we are thrilled with the ERC’s decision to award us their highly competitive Advanced grant. It is encouraging to know that others also believe in our idea, which has been in the pipeline for a while but without the resources to see it through. The grant will allow us to expand our translational research with the aim to bring new and effective anti-cancer therapies to patients.

Advertisement

Filed under: Uncategorized   |  Leave a Comment